Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  52,059 results for ""RITUXIMAB""

Your Filters

Filter by : Subject
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Effect of Immunosuppression on the Immune Response to SARS-CoV-2 Infection and Vaccination.

Subjects: COVID-19*/COVID-19*/COVID-19*/immunology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/virology

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 May 11; Vol. 25 (10). Date of Electronic Publication: 2024 May 11.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

Read More Add to Saved list
×
Academic Journal

PD-1 Receptor (+) T cells are associated with the efficacy of the combined treatment with regulatory t cells and rituximab in type 1 diabetes children via regulatory t cells suppressive activity amelioration.

  • Authors : Zieliński M; Department of Medical Immunology, Medical University of Gdańsk, Debinki 7 80-210, Poland; Poltreg S.A., Botaniczna 20 Street, 80-298 Gdańsk, Poland.

Subjects: Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/immunology ; Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy ; T-Lymphocytes, Regulatory*/T-Lymphocytes, Regulatory*/T-Lymphocytes, Regulatory*/immunology

  • Source: International immunopharmacology [Int Immunopharmacol] 2024 May 10; Vol. 132, pp. 111919. Date of Electronic Publication: 2024 Mar 30.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Infection incidence, timing and dose dependency in rheumatoid arthritis patients treated with rituximab: a retrospective cohort study.

  • Authors : Veeken LD; Department of Rheumatology, Sint Maartenskliniek, Nijmegen, The Netherlands.; Opdam MAA

Subjects: Rituximab*/Rituximab*/Rituximab*/administration & dosage ; Rituximab*/Rituximab*/Rituximab*/adverse effects ; Rituximab*/Rituximab*/Rituximab*/therapeutic use

  • Source: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2024 May 02; Vol. 63 (5), pp. 1246-1250.Publisher: Oxford University Press Country of Publication: England NLM ID: 100883501 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

A predictive nomogram for short-term outcomes of myasthenia gravis patients treated with low-dose rituximab.

  • Authors : Zhou Y; Department of Neurology, Huashan Hospital, Fudan University, Shanghai, China.; Huashan Rare Disease Center, Huashan Hospital, Fudan University, Shanghai, China.

Subjects: Rituximab*/Rituximab*/Rituximab*/therapeutic use ; Rituximab*/Rituximab*/Rituximab*/administration & dosage ; Myasthenia Gravis*/Myasthenia Gravis*/Myasthenia Gravis*/drug therapy

  • Source: CNS neuroscience & therapeutics [CNS Neurosci Ther] 2024 May; Vol. 30 (5), pp. e14761.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101473265 Publication Model: Print Cited Medium: Internet ISSN: 1755-5949

Record details

Read More Add to Saved list
×
Academic Journal

Impact of rituximab treatment regime on time to relapse in aquaporin-4 antibody positive neuromyelitis optica spectrum disorder.

  • Authors : Nasir M; Department of Neurology, The Royal London Hospital, Barts Health NHS Trust, London, United Kingdom.; Hone L

Subjects: Neuromyelitis Optica*/Neuromyelitis Optica*/Neuromyelitis Optica*/drug therapy ; Rituximab*/Rituximab*/Rituximab*/administration & dosage ; Rituximab*/Rituximab*/Rituximab*/pharmacology

  • Source: Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2024 May; Vol. 85, pp. 105528. Date of Electronic Publication: 2024 Mar 07.Publisher: Elsevier B. V Country of Publication: Netherlands NLM ID: 101580247 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Single agent vemurafenib or rituximab-vemurafenib combination for the treatment of relapsed/refractory hairy cell leukemia, a multicenter experience.

  • Authors : Yiğit Kaya S; Department of Hematology, Faculty of Medicine, Istanbul Medipol University, Turkey. Electronic address: .; Mutlu YG

Subjects: Leukemia, Hairy Cell*/Leukemia, Hairy Cell*/Leukemia, Hairy Cell*/drug therapy ; Leukemia, Hairy Cell*/Leukemia, Hairy Cell*/Leukemia, Hairy Cell*/pathology ; Vemurafenib*/Vemurafenib*/Vemurafenib*/administration & dosage

  • Source: Leukemia research [Leuk Res] 2024 May; Vol. 140, pp. 107495. Date of Electronic Publication: 2024 Mar 29.Publisher: Pergamon Press Country of Publication: England NLM ID: 7706787 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

LncRNA CHROMR/miR-27b-3p/MET axis promotes the proliferation, invasion, and contributes to rituximab resistance in diffuse large B-cell lymphoma.

  • Authors : Liu C; Department of Biochemistry and Molecular Biology, Changzhi Medical College, Changzhi, Shanxi, China; Department of Biochemistry and Molecular Biology, Shanxi Medical University, Taiyuan, Shanxi, China.

Subjects: Carcinogenesis*/Carcinogenesis*/Carcinogenesis*/genetics ; Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/genetics ; Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/metabolism

  • Source: The Journal of biological chemistry [J Biol Chem] 2024 Mar; Vol. 300 (3), pp. 105762. Date of Electronic Publication: 2024 Feb 16.Publisher: Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology Country of Publication: United States NLM ID: 2985121R Publication

Record details

Read More Add to Saved list
×
Academic Journal

Efficacy and safety of netupitant/palonosetron in preventing nausea and vomiting in diffuse large B cell lymphoma patients undergoing R-CHOP chemotherapy.

  • Authors : Kwak K; Division of Hematology-Oncology, Department of Internal Medicine, Korea University College of Medicine, 73, Goryeodae-Ro, Seongbuk-Gu, Seoul, 02841, Republic of Korea.; Park Y

Subjects: Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/drug therapy ; Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/adverse effects ; Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/therapeutic use

  • Source: Scientific reports [Sci Rep] 2024 May 16; Vol. 14 (1), pp. 11229. Date of Electronic Publication: 2024 May 16.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Editorial & Opinion

Evaluation of cardiac function in patients with pemphigus vulgaris before and after rituximab infusion.

  • Authors : Jafari M; Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.; Pighgahi M

Subjects: Pemphigus*/Pemphigus*/Pemphigus*/drug therapy ; Pemphigus*/Pemphigus*/Pemphigus*/diagnosis ; Rituximab*/Rituximab*/Rituximab*/administration & dosage

  • Source: Archives of dermatological research [Arch Dermatol Res] 2024 May 11; Vol. 316 (5), pp. 170. Date of Electronic Publication: 2024 May 11.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8000462 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-069X

Record details

Read More Add to Saved list
×
Academic Journal

Plasmapheresis combined with rituximab treatment of a case of thrombotic thrombocytopenic purpura with Sjögren syndrome and renal impairment: A case report.

  • Authors : Zhang Y; Guizhou University of Traditional Chinese Medicine, Guiyang 550002, Guizhou, China.; Hu S

Subjects: Sjogren's Syndrome*/Sjogren's Syndrome*/Sjogren's Syndrome*/complications ; Sjogren's Syndrome*/Sjogren's Syndrome*/Sjogren's Syndrome*/therapy ; Plasmapheresis*/Plasmapheresis*/Plasmapheresis*/methods

  • Source: Medicine [Medicine (Baltimore)] 2024 May 10; Vol. 103 (19), pp. e38103.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  52,059 results for ""RITUXIMAB""